GMI

Nanoemulsion potentiates the anti-cancer activity of myricetin by effective inhibition of PI3K/AKT/mTOR pathway in triple-negative breast cancer cells.

n/a


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *